Cell and Gene Outsourcing

  1. NGS Bioinformatics Pipelines For Enhanced Viral Vector QC And Analytics 12/15/2025

    Advanced NGS bioinformatics pipelines ensure viral vector integrity, detect contaminants, and predict splicing patterns, enabling precise quality control for safer, more effective gene therapy development.

  2. Enhancing Lentiviral Vector Titre By Limiting Auto-Transduction 12/15/2025

    Limiting auto-transduction with Additive X boosts lentiviral vector titres by 4.2-fold, reduces reintegration events, and optimizes continuous production processes for advanced cell therapy applications.

  3. An End-To-End Partner From Concept To Clinic 12/15/2025

    Explore the full scope of integrated services spanning multiple advanced therapy modalities, development, and GMP manufacturing. Flexible engagement models support programs from concept to clinic.

  4. CRO Selection Science: Insights From $2B+ Vendor Choices 12/15/2025

    Discover how data-driven strategies and structured RFPs can simplify CRO selection, improve transparency, and ensure the right operational fit. Learn practical steps to make smarter vendor decisions.

  5. Doubling Up For Speed In Biomanufacturing 12/12/2025

    Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

  6. CDMO Or No CDMO... That Is The Question 12/12/2025

    Success depends on assessing internal capabilities and knowing when outsourcing can accelerate timelines. Learn how strategic decisions reduce risk, avoid costly delays, and keep your organization competitive.

  7. Choosing The Best mRNA Manufacturing Strategy 12/12/2025

    Choosing the right mRNA manufacturing model can define your success. Learn how to weigh control, cost, and flexibility to build a strategy that supports innovation and long-term growth.

  8. CDMOs - Key Collaborators In Streamlining Drug Development 12/12/2025

    Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.

  9. Scaling Up Bioprocesses Through A CDMO 12/12/2025

    Scaling biopharma processes is complex. Learn how flexibility, single-use systems, and strategic partnerships are helping manufacturers overcome these challenges and accelerate time to market.

  10. Defining Specificity Within The ELISpot Assay 12/12/2025

    Achieving high-quality T cell ELISpot results requires robust controls to verify antigen-specific activation. Learn the experiments and best practices for establishing and confirming assay specificity.